HER2CLIMB: Sequencing in Metastatic Breast Cancer
3 Pogledi
• 07/03/23
0
0
Ugraditi
administrator
Pretplatnici
Given other methods used to treat HER2-positive metastatic breast cancer, Erika P. Hamilton, MD, considers tucatinib’s role in sequencing.
Website: https://www.onclive.com
Twitter: https://twitter.com/OncLive
Facebook: https://www.facebook.com/OncLive/
LinkedIn: https://www.linkedin.com/company/onclive
Prikaži više
Komentari na Facebooku
SORT BY-
Najbolji komentari
-
Najnoviji komentari